Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

被引：3

作者：

Rose, Tracy L. ^{[1
,2
]}

Harrison, Michael Roger ^{[3
]}

Deal, Allison Mary ^{[2
]}

Osterman, Chelsea K. ^{[4
]}

Ramalingam, Sundhar ^{[5
]}

Whang, Young E. ^{[6
]}

Brower, Blaine Y. ^{[7
]}

Bjurlin, Marc ^{[6
]}

Smith, Angela B. ^{[6
]}

Nielsen, Matthew E. ^{[6
]}

Tan, Hung-Jui ^{[6
]}

Wallen, Eric M. ^{[6
]}

George, Daniel J. ^{[3
]}

Zhang, Tian ^{[3
]}

Drier, Anthony ^{[6
]}

Kim, William Y. ^{[2
]}

Milowsky, Matthew, I ^{[7
]}

机构：

[1] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA

[2] UNC, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[3] Duke Univ, Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC USA

[4] Univ N Carolina, Dept Med, Div Oncol, Chapel Hill, NC 27515 USA

[5] Duke Canc Inst, Durham, NC USA

[6] Univ N Carolina, Chapel Hill, NC 27515 USA

[7] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27515 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期

关键词：

D O I：

10.1200/JCO.2021.39.6_suppl.396

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

396

引用

页数：2

共 50 条

[21] Perioperative Study in muscle-invasive Bladder Cancer (MIBC) with Indication for radical Cystectomy
Rexer, H.
Boegemann, Martin
Ret, M.
[J]. UROLOGIE, 2024, 63 (09): : 970 - 971
[22] Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC).
Galsky, Matt D.
Harshman, Lauren Christine
Crabb, Simon J.
Wong, Yu-Ning
Yu, Evan Y.
Chowdhury, Simon
Powles, Thomas
Pal, Sumanta Kumar
Moshier, Erin L.
Ladoire, Sylvain
Hussain, Syed A.
Agarwal, Neeraj
Vaishampayan, Ulka N.
Recine, Federica
Berthold, Dominik
Necchi, Andrea
Theodore, Christine
Milowsky, Matthew I.
Bellmunt, Joaquim
Rosenberg, Jonathan E.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[23] KEYNOTE-905: A phase III study of cystectomy plus perioperative pembrolizumab versus cystectomy alone in cisplatin (cis)-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC)
Galsky, M.
Necchi, A.
Shore, N. D.
Witjes, F.
Nam, K.
Godwin, J. L.
Frenkl, T. L.
Plimack, E. R.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[24] Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).
Tsironis, George
Zakopoulou, Roubini
Koutsoukos, Konstantinos
Tzanis, Kimon
Varkarakis, John
Papatsoris, Athanasios
Stravodimos, Kostas
Kostouros, Efthymios
Fragkoulis, Charalampos
Choreftaki, Theodosia
Filippiadis, Dimitrios
Fontara, Sofia
Dellis, Athanasios
Ntai, Sparti
Zygogianni, Anna
Ntoumas, Konstantinos
Constantinides, Constantinos A.
Korkolopoulou, Penelope
Dimopoulos, Meletios A.
Bamias, Aristotelis
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[25] Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
Pichler, Renate
Fritz, Josef
Mari, Andrea
Cadenar, Anna
von Deimling, Markus
Marcq, Gautier
del Giudice, Francesco
Leonardo, Costantino
Bologna, Eugenio
Mori, Keiichiro
Tahbaz, Rana
De Santis, Maria
Klatte, Tobias
Erber, Barbara
Lackner, Felizian
Kronbichler, Andreas
Seeber, Andreas
Fisch, Margit
Moschini, Marco
Pradere, Benjamin
Mertens, Laura S.
[J]. ONCOLOGIST, 2024,
[26] Identifying high surgical risk in muscle-invasive bladder cancer (MIBC) patients undergoing radical cystectomy (RC)
Marqueen, Kathryn E.
Waingankar, Nikhil
Sfakianos, John
Mehrazin, Reza
Niglio, Scot Anthony
Audenet, Francois
Jia, Rachel
Mazumdar, Madhu
Ferket, Bart
Galsky, Matt D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[27] JaNEO - A phase Ib/II study assessing the neo-adjuvant combination therapy of vinflunine (VFL) with cisplatin (CDDP) followed by radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC)
Hegele, A.
Ohlmann, C-H.
Rexer, H.
Gakis, G.
[J]. ANNALS OF ONCOLOGY, 2016, 27
[28] Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
Balar, Arjun Vasant
Iyer, Gopa
Milowsky, Matthew I.
Huang, William C.
Woods, Michael
Donat, S. Machele
Herr, Harry W.
Dalbagni, Guido
Bochner, Bernard H.
Ostrovnaya, Irina
Al-Ahmadie, Hikmat
Rose, Tracy Lynn
Riches, Jamie Cathleen
Kania, Brooke Elizabeth
Regazzi, Ashley Marie
Mccoy, Asia S.
Delbeau, Daniela
Rosenberg, Jonathan E.
Bajorin, Dean F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[29] PHASE 2 TRIAL OF NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOR MUSCLE-INVASIVE BLADDER CANCER FOLLOWED BY RADICAL CYSTECTOMY
Koie, Takuya
Okamoto, Teppei
Imanishi, Kengo
Sugiyama, Naoki
Kudoh, Shigemasa
Mori, Kazuyuki
Tachiwada, Tokushi
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Kamimura, Noritaka
Ohyama, Chikara
Suzuki, Yuichiro
[J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E657 - E657
[30] Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M. H. Einerhand
Anna J. Black
Homayoun Zargar
Adrian S. Fairey
Colin P. Dinney
Maria C. Mir
Laura-Maria Krabbe
Michael S. Cookson
Niels-Erik Jacobson
Jeffrey S. Montgomery
Nikhil Vasdev
Evan Y. Yu
Evanguelos Xylinas
Wassim Kassouf
Marc A. Dall’Era
Srikala S. Sridhar
Jonathan S. McGrath
Jonathan Aning
Shahrokh F. Shariat
Jonathan L. Wright
Andrew C. Thorpe
Todd M. Morgan
Jeff M. Holzbeierlein
Trinity J. Bivalacqua
Scott North
Daniel A. Barocas
Yair Lotan
Petros Grivas
Jorge A. Garcia
Andrew J. Stephenson
Jay B. Shah
Siamak Daneshmand
Kamran Zargar-Shoshtari
Philippe E. Spiess
Bas W. G. van Rhijn
Peter C. Black
Laura S. Mertens
[J]. World Journal of Urology, 2022, 40 : 2707 - 2715

← 1 2 3 4 5 →